PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 15.88
-0.18 (-1.12%)
Apr 4, 2025, 11:41 AM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 529.92 million as of April 4, 2025. Its market cap has decreased by -34.34% in one year.
Market Cap
529.92M
Enterprise Value
564.27M
Revenue
315.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.88
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 529.92M, a decrease of -79.54%. That is a compound annual growth rate of -33.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 529.92M | -43.43% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 232.76B |
| Novartis AG | 185.66B |
| Alcon | 41.16B |
| Lonza Group AG | 39.16B |
| Galderma Group AG | 22.21B |
| Straumann Holding AG | 16.89B |
| Sandoz Group AG | 15.95B |
| Sonova Holding AG | 15.29B |